Patents

US 8822435 B2: Bisphosphonate compounds

Granted
2014-09-02
Filed
2014-03-12 application 14205937
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Novel bisphosphonate cyclic acetal compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating bone metabolism disorders, such as abnormal calcium and phosphate metabolism.

Source: PVGPATDIS, file of 2026-04-10 (ipg140902.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Warner Chilcott Company, LLC 27 patentsUS company or organizationFajardo, PRWARNER CHILCOTT COMPANY, LLC State business registration EXACT high confidence: identical full name and state
WARNER CHILCOTT PLC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Frank Hallock EbetinoCincinnati, OH14PVGPATDIS, file of 2026-04-10
Adam W. MazurMason, OH5PVGPATDIS, file of 2026-04-10
Roy Lee Martin DobsonHamilton, OH3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or telluriumC07F9/65746PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/12PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-02-22Correction
Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment.
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1745417/593PASDL, file of 2026-10-15
2016-09-29Assignment
Assignment of assignor's interest
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1740183/129PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.